Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

ACOG

Alpha Cognition (ACOG)

Alpha Cognition Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:ACOG
FechaHoraFuenteTítuloSímboloCompañía
12/02/202507:30Business WireAlpha Cognition Secures Additional U.S. Patent for ZUNVEYL (benzgalantamine) in the Treatment of Mild to Moderate Alzheimer’s diseaseNASDAQ:ACOGAlpha Cognition Inc
22/01/202506:00GlobeNewswire Inc.OTC Markets Group Announces Quarterly Index Performance and RebalancingNASDAQ:ACOGAlpha Cognition Inc
14/01/202507:30Business WireAlpha Cognition Expands Commercial and Medical Teams with Key Leadership Hires to Support the Launch of ZUNVEYLNASDAQ:ACOGAlpha Cognition Inc
10/01/202505:20Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:ACOGAlpha Cognition Inc
10/01/202505:12Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:ACOGAlpha Cognition Inc
08/01/202507:30Business WireAlpha Cognition Announces a $44 Million Exclusive Licensing Agreement for the Development and Commercialization of ZUNVEYL (benzgalantamine), an FDA-Approved Treatment for Mild-to-Moderate Alzheimer’s Disease, in ChinaNASDAQ:ACOGAlpha Cognition Inc
06/01/202507:30Business WireAlpha Cognition to Present Q1 2025 ZUNVEYL (benzgalantamine) Launch Strategy Targeting the $2 Billion U.S. Alzheimer’s Long-Term Care Market During Investor Update CallNASDAQ:ACOGAlpha Cognition Inc
16/12/202413:56Business WireAlpha Cognition Announces Partial Exercise of Over-allotment OptionNASDAQ:ACOGAlpha Cognition Inc
12/12/202417:41Business WireAlpha Cognition Announces Voluntary Delisting from CSENASDAQ:ACOGAlpha Cognition Inc
11/12/202407:30Business WireAlpha Cognition Announces Positive Interim Pre-Clinical Data for ALPHA-1062 Use in a Military Relevant Model of Repetitive Mild Traumatic Brain InjuryNASDAQ:ACOGAlpha Cognition Inc
15/11/202416:00Business WireAlpha Cognition Announces Financial Results for the Second Quarter and Six Months Ended June 2024 and Provides Corporate UpdateNASDAQ:ACOGAlpha Cognition Inc
12/11/202408:22Business WireAlpha Cognition Announces Pricing of $50 Million Upsized Public Offering and Nasdaq ListingNASDAQ:ACOGAlpha Cognition Inc
 Showing the most relevant articles for your search:NASDAQ:ACOG